Bacterial coinfections in COVID-19 : an underestimated adversary
Current literature shows that secondary bacterial infections, although less frequent than in previous influenza pandemics, affect COVID-19 patients. Mycoplasma pneumoniae, Staphylococcus aureus, Legionella pneumophila, Streptococcus pneumoniae, Haemophilus and Klebsiella spp. are the main species isolated. Of note, Mycobacterium tuberculosis-COVID-19 coinfections are also reported. However, bacterial coinfection rates increase in patients admitted in the intensive care units, and those diseases can be due to super-infections by nosocomial antibiotic-resistant bacteria. This highlights the urgency to revise frequent and empiric prescription of broad-spectrum antibiotics in COVID-19 patients, with more attention to evidence-based studies and respect for the antimicrobial stewardship principles.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:56 |
---|---|
Enthalten in: |
Annali dell'Istituto superiore di sanita - 56(2020), 3 vom: 30. Juli, Seite 359-364 |
Sprache: |
Englisch |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 02.10.2020 Date Revised 18.12.2020 published: Print Citation Status MEDLINE |
---|
doi: |
10.4415/ANN_20_03_14 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM315310421 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM315310421 | ||
003 | DE-627 | ||
005 | 20231225154631.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.4415/ANN_20_03_14 |2 doi | |
028 | 5 | 2 | |a pubmed24n1050.xml |
035 | |a (DE-627)NLM315310421 | ||
035 | |a (NLM)32959802 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Fattorini, Lanfranco |e verfasserin |4 aut | |
245 | 1 | 0 | |a Bacterial coinfections in COVID-19 |b an underestimated adversary |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 02.10.2020 | ||
500 | |a Date Revised 18.12.2020 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Current literature shows that secondary bacterial infections, although less frequent than in previous influenza pandemics, affect COVID-19 patients. Mycoplasma pneumoniae, Staphylococcus aureus, Legionella pneumophila, Streptococcus pneumoniae, Haemophilus and Klebsiella spp. are the main species isolated. Of note, Mycobacterium tuberculosis-COVID-19 coinfections are also reported. However, bacterial coinfection rates increase in patients admitted in the intensive care units, and those diseases can be due to super-infections by nosocomial antibiotic-resistant bacteria. This highlights the urgency to revise frequent and empiric prescription of broad-spectrum antibiotics in COVID-19 patients, with more attention to evidence-based studies and respect for the antimicrobial stewardship principles | ||
650 | 4 | |a Journal Article | |
700 | 1 | |a Creti, Roberta |e verfasserin |4 aut | |
700 | 1 | |a Palma, Carla |e verfasserin |4 aut | |
700 | 1 | |a Pantosti, Annalisa |e verfasserin |4 aut | |
700 | 0 | |a Unit of Antibiotic Resistance and Special Pathogens |e verfasserin |4 aut | |
700 | 0 | |a Unit of Antibiotic Resistance and Special Pathogens of the Department of Infectious Diseases, Istituto Superiore di Sanità, Rome |e verfasserin |4 aut | |
700 | 1 | |a Fattorini, Lanfranco |e investigator |4 oth | |
700 | 1 | |a Creti, Roberta |e investigator |4 oth | |
700 | 1 | |a Palma, Carla |e investigator |4 oth | |
700 | 1 | |a Pantosti, Annalisa |e investigator |4 oth | |
700 | 1 | |a Barbanti, Fabrizio |e investigator |4 oth | |
700 | 1 | |a Camilli, Romina |e investigator |4 oth | |
700 | 1 | |a Ciervo, Alessandra |e investigator |4 oth | |
700 | 1 | |a Dattilo, Rosanna |e investigator |4 oth | |
700 | 1 | |a Del Grosso, Maria |e investigator |4 oth | |
700 | 1 | |a Errico, Giulia |e investigator |4 oth | |
700 | 1 | |a Fortini, Daniela |e investigator |4 oth | |
700 | 1 | |a Garcia Fernandez, Aurora |e investigator |4 oth | |
700 | 1 | |a Giannoni, Federico |e investigator |4 oth | |
700 | 1 | |a Giufré, Maria |e investigator |4 oth | |
700 | 1 | |a Imperi, Monica |e investigator |4 oth | |
700 | 1 | |a Lucarelli, Claudia |e investigator |4 oth | |
700 | 1 | |a Mancini, Fabiola |e investigator |4 oth | |
700 | 1 | |a Monaco, Monica |e investigator |4 oth | |
700 | 1 | |a Mondello, Francesca |e investigator |4 oth | |
700 | 1 | |a Pimentel de Araujo, Fernanda |e investigator |4 oth | |
700 | 1 | |a Ricci, Maria Luisa |e investigator |4 oth | |
700 | 1 | |a Scaturro, Maria |e investigator |4 oth | |
700 | 1 | |a Spigaglia, Patrizia |e investigator |4 oth | |
700 | 1 | |a Torosantucci, Antonella |e investigator |4 oth | |
700 | 1 | |a Villa, Laura |e investigator |4 oth | |
773 | 0 | 8 | |i Enthalten in |t Annali dell'Istituto superiore di sanita |d 1967 |g 56(2020), 3 vom: 30. Juli, Seite 359-364 |w (DE-627)NLM000417572 |x 2384-8553 |7 nnns |
773 | 1 | 8 | |g volume:56 |g year:2020 |g number:3 |g day:30 |g month:07 |g pages:359-364 |
856 | 4 | 0 | |u http://dx.doi.org/10.4415/ANN_20_03_14 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 56 |j 2020 |e 3 |b 30 |c 07 |h 359-364 |